Location History:
- Saint Louis, MO (US) (2009)
- St Louis, MO (US) (2020)
- St. Louis, MO (US) (2015 - 2024)
Company Filing History:
17 out of 141 
1 out of 145 
Years Active: 2009-2025
Title: Innovations by Fuqiang Chen: A Pioneer in Genome Modification
Introduction: Fuqiang Chen, an accomplished inventor based in St. Louis, MO, holds a remarkable portfolio of 17 patents. His pioneering work in genetic engineering has significantly advanced the field of genome modification, making him a notable figure among contemporary inventors.
Latest Patents: Two of Fuqiang Chen's latest patents exemplify his innovative contributions to the field. The first patent focuses on "Engineered CAS9 systems for eukaryotic genome modification." This invention includes engineered Cas9 systems that utilize alternate protospacer adjacent motifs for target DNA binding. It encompasses nucleic acids encoding these systems and methods for modifying target chromosomal sequences in eukaryotic cells. The second patent revolves around "Using programmable DNA binding proteins to enhance targeted genome modification." This invention details compositions and methods that employ programmable DNA binding proteins to improve the efficiency and specificity of targeted genome modification. Additionally, it facilitates the detection of specific genomic loci in eukaryotic cells.
Career Highlights: Fuqiang Chen has made significant strides in his career through his work with prominent companies, including Sigma-Aldrich Co. LLC and Sangamo Therapeutics, Inc. His expertise and commitment to innovation have played a critical role in advancing genetic engineering technologies.
Collaborations: Throughout his career, Fuqiang Chen has collaborated with esteemed professionals in the field, such as Gregory D. Davis and Xiao Ding. These partnerships have enriched his research and contributed to the success of his innovative projects.
Conclusion: Fuqiang Chen is a key figure in the realm of genome modification, with a strong track record of patents that underscore his innovative spirit. His contributions continue to shape the future of genetic engineering, paving the way for new advancements in the field.